Cleopatra Hospitals Group results, Q4 2024
Net profit, assets, equity and cash flow for Q4 2024, against the same period a year earlier, from the published financial statements.
Net profit191 millionEGP · +78.1% vs the same period a year earlier
Total assets7.59 billionEGP · +69.1% vs the same period a year earlier
Shareholders' equity3.18 billionEGP · +29.9% vs the same period a year earlier
Operating cash flow394 millionEGP · +144.5% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q4 2024 was about 191 million EGP, up +78.1% from 107 million EGP in Q4 2023.
- Total assets at the end of Q4 2024 were about 7.59 billion EGP, and shareholders' equity about 3.18 billion EGP.
- Operating cash flow for Q4 2024 was positive at 394 million EGP.
Key lines against the same period a year earlier
This periodQ4 2023Change
Net profit191 million107 million+78.1%
Gross profit654 million408 million+60.4%
Total assets7.59 billion4.49 billion+69.1%
Total liabilities4.41 billion2.04 billion+116.1%
Shareholders' equity3.18 billion2.45 billion+29.9%
Total liabilities and equity7.59 billion4.49 billion+69.1%
Operating cash flow394 million161 million+144.5%
Investing cash flow-617 million-290 million−113.3%
Financing cash flow301 million153 million+97.2%
Net change in cash77.62 million24.35 million+218.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy